Experienced in Anton Syndrome

Dr. Alfredo A. Sadun

Ophthalmology
Jules Stein Eye Institute Medical Group
622 W Duarte Rd, Suite 101, 
Arcadia, CA 
Experienced in Anton Syndrome
Jules Stein Eye Institute Medical Group
622 W Duarte Rd, Suite 101, 
Arcadia, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Alfredo Sadun is an Ophthalmologist in Arcadia, California. Dr. Sadun is rated as an Experienced provider by MediFind in the treatment of Anton Syndrome. His top areas of expertise are Leber Hereditary Optic Neuropathy (LHON), Optic Nerve Atrophy, Papilledema, Vitrectomy, and Hormone Replacement Therapy (HRT).

His clinical research consists of co-authoring 184 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Ophthalmology
Licenses
Ophthalmology in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VIVA Health
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

JULES STEIN EYE INSTITUTE MEDICAL GROUP
622 W Duarte Rd, Suite 101, Arcadia, CA 91007

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Long-term Follow-up of ND4 LHON Subjects Treated With GS010 Ocular Gene Therapy in the RESCUE or REVERSE Phase III Clinical Trials (RESTORE)
Long-term Follow-up of ND4 LHON Subjects Treated With GS010 Ocular Gene Therapy in the RESCUE or REVERSE Phase III Clinical Trials (RESTORE)
Enrollment Status: Completed
Publish Date: September 09, 2025
Intervention Type: Genetic, Other
Study Phase: Phase 3
Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year
Efficacy and Safety of Bilateral Intravitreal Injection of GS010: A Randomized, Double-Masked, Placebo-Controlled Trial in Subjects Affected With G11778A ND4 Leber Hereditary Optic Neuropathy for Up to One Year
Enrollment Status: Completed
Publish Date: August 26, 2025
Intervention Type: Drug, Genetic
Study Phase: Phase 3
A Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for 6 Months or Less by LHON Due to the G11778A Mutation in the Mitochondrial ND4 Gene
A Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for 6 Months or Less by LHON Due to the G11778A Mutation in the Mitochondrial ND4 Gene
Enrollment Status: Completed
Publish Date: July 29, 2022
Intervention Type: Biological, Device
Study Phase: Phase 3
Observational Registry Study of Leber Hereditary Optic Neuropathy (LHON) Affected Patients
Observational Registry Study of Leber Hereditary Optic Neuropathy (LHON) Affected Patients
Enrollment Status: Completed
Publish Date: February 08, 2021
Intervention Type: Other
Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for More Than 6 Months and To 12 Months by LHON Due to the G11778A Mutation in the ND4 Gene
Randomized, Double-Masked, Sham-Controlled Clinical Trial to Evaluate the Efficacy of a Single Intravitreal Injection of GS010 in Subjects Affected for More Than 6 Months and To 12 Months by LHON Due to the G11778A Mutation in the ND4 Gene
Enrollment Status: Completed
Publish Date: January 23, 2020
Intervention Type: Biological, Device
Study Phase: Phase 3
View 4 Less Clinical Trials

184 Total Publications

Vitreous Floaters Functional Questionnaire for Vision-Degrading Myodesopsia From Vitreous Floaters.
Vitreous Floaters Functional Questionnaire for Vision-Degrading Myodesopsia From Vitreous Floaters.
Journal: JAMA ophthalmology
Published: October 02, 2025
Similar Doctors
Distinguished in Anton Syndrome
Dr. Mark Borchert
Ophthalmology
Distinguished in Anton Syndrome
Dr. Mark Borchert
Ophthalmology
4650 W Sunset Blvd, 
Los Angeles, CA 
 (13.8 miles away)
213-669-4510
Languages Spoken:
English
See accepted insurances

Mark Borchert is an Ophthalmologist in Los Angeles, California. Dr. Borchert is rated as a Distinguished provider by MediFind in the treatment of Anton Syndrome. His top areas of expertise are Strabismus, Anton Syndrome, Oculomotor Apraxia Cogan Type, and Papilledema.

Experienced in Anton Syndrome
Dr. Thomas G. Chu
Ophthalmology
Experienced in Anton Syndrome
Dr. Thomas G. Chu
Ophthalmology
16661 Ventura Boulevard, Penthouse 900, 
Encino, CA 
 (25.5 miles away)
818-578-7408
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Thomas Chu is an Ophthalmologist in Encino, California. Dr. Chu is rated as a Distinguished provider by MediFind in the treatment of Anton Syndrome. His top areas of expertise are Diabetic Retinopathy, Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, and Retinal Detachment. Dr. Chu is currently accepting new patients.

Experienced in Anton Syndrome
Dr. Alfred C. Marrone
Ophthalmology
Experienced in Anton Syndrome
Dr. Alfred C. Marrone
Ophthalmology
23441 Madison Street, Suite 120, 
Torrance, CA 
 (27.5 miles away)
310-373-6708
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Alfred Marrone is an Ophthalmologist in Torrance, California. Dr. Marrone is rated as an Advanced provider by MediFind in the treatment of Anton Syndrome. His top areas of expertise are Conjunctivitis (Pink Eye), Eyelid Drooping, Ptosis, and Cataract. Dr. Marrone is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Sadun's expertise for a condition
ConditionClose
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile